scispace - formally typeset
A

Andrea Kopp Lugli

Researcher at University Hospital of Basel

Publications -  7
Citations -  218

Andrea Kopp Lugli is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: Perioperative & Internal medicine. The author has an hindex of 4, co-authored 6 publications receiving 183 citations. Previous affiliations of Andrea Kopp Lugli include University of Basel.

Papers
More filters
Journal ArticleDOI

Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia.

TL;DR: The story of anaesthesia mechanisms research from its historical roots to the intensely neurophysiological research regarding it today is followed, and recent findings that identify specific neuroanatomical locations mediating the actions of some anaesthetic agents are described.
Journal ArticleDOI

Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trial.

TL;DR: The design and protocol of a randomized controlled trial investigating the optimal timing of surgical antimicrobial prophylaxis will have an important impact on current international guidelines for infection control strategies in the hospital and are of significant interest for patient safety and healthcare economics.
Journal ArticleDOI

Medical Nutrition Therapy in Critically Ill Patients Treated on Intensive and Intermediate Care Units: A Literature Review

TL;DR: Current knowledge and guidelines on medical nutrition therapy for critically ill patients are addressed in order to summarize how they can be best implemented into daily clinical practice.
Journal ArticleDOI

The Role of HbA1c as a Positive Perioperative Predictor of Surgical Site and Other Postoperative Infections: An Explorative Analysis in Patients Undergoing Minor to Major Surgery.

TL;DR: In this paper, the impact of surgical and metabolic stress as defined by the surrogate marker hemoglobin A1c (HbA1c), in relation to self-reported DM2, on perioperative infection rates in a subcohort of the Surgical Site Infection (SSI) Trial population was analyzed.